Lenvatinib治疗放射性碘难治性分化型甲状腺癌:优化治疗以获得最大临床效益

Opuholi Golovy i Šei Pub Date : 2023-03-09 DOI:10.17650/2222-1468-2022-12-4-81-90
L. J. Wirth, C. Durante, D. J. Topliss, E. Winquist, E. Robenshtok, H. Iwasaki, M. Luster, R. Elisei, S. Leboulleux, M. Tahara
{"title":"Lenvatinib治疗放射性碘难治性分化型甲状腺癌:优化治疗以获得最大临床效益","authors":"L. J. Wirth, C. Durante, D. J. Topliss, E. Winquist, E. Robenshtok, H. Iwasaki, M. Luster, R. Elisei, S. Leboulleux, M. Tahara","doi":"10.17650/2222-1468-2022-12-4-81-90","DOIUrl":null,"url":null,"abstract":".","PeriodicalId":19610,"journal":{"name":"Opuholi Golovy i Šei","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit\",\"authors\":\"L. J. Wirth, C. Durante, D. J. Topliss, E. Winquist, E. Robenshtok, H. Iwasaki, M. Luster, R. Elisei, S. Leboulleux, M. Tahara\",\"doi\":\"10.17650/2222-1468-2022-12-4-81-90\",\"DOIUrl\":null,\"url\":null,\"abstract\":\".\",\"PeriodicalId\":19610,\"journal\":{\"name\":\"Opuholi Golovy i Šei\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Opuholi Golovy i Šei\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/2222-1468-2022-12-4-81-90\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Opuholi Golovy i Šei","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2222-1468-2022-12-4-81-90","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

．
本文章由计算机程序翻译，如有差异，请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit
.
求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
Opuholi Golovy i Šei
Opuholi Golovy i Šei
自引率
0.00%
发文量
0
期刊最新文献
Review of clinical cases of internal organ metastases into the skin of the head and neck Spontaneous necrosis of parathyroid adenoma: clinical observation Reactive astrocytes and glioblastoma: are there new targets for more effective antitumor therapy? Evaluation of the quality of neck dissection in patients with oral cavity squamous cell carcinoma PD-L1 and p53 expression in squamous cell carcinoma of the oropharynx depending on human papilloma virus status
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1